Passkey Therapeutics

Passkey Therapeutics is a biotech company in Cambridge, United States, founded in 2024. It has raised $20.0M across 1 round, most recently a $20.0M Seed in October 2024.

Unlocking a trove of clinic-ready synergistic therapeutics

Employees
1–10
Founded
2024
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M SeedOct 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

Passkey Therapeutics is pioneering a new class of medicines called Synergistic Multifunctional Therapeutics (SMThs), designed to address complex diseases by engaging multiple biological targets simultaneously. The companys proprietary Locksmith platform maps synergistic pharmacology using human genetics, biology, and pharmacology data across 4,000 approved drugs and 600 billion genetic variants to identify powerful drug combinations. Because Locksmith identifies combinations using approved and late-stage drugs, programs can bypass traditional preclinical development and proceed directly to human proof-of-concept clinical trials. Passkey partners with pharma companies to unlock clinic-ready combination therapies across oncology and other complex diseases with unmet need.

Summary

It lists 1–10 employees. It has raised $20.0M in total across 1 round, most recently a $20.0M Seed round in Oct 2024. Investors include Breakout Ventures, Innovation Endeavors and Bison Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedOct 2024
$20.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Passkey Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/passkey-therapeutics"><img src="https://indexed.vc/api/badge/company/passkey-therapeutics" alt="Passkey Therapeutics on Indexed.vc" width="260" height="76" /></a>